Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-27 Purchase |
2024-09-30 7:12 pm |
Viridian Therapeutics Inc. | VRDN | Beetham Thomas W. Chief Operating Officer |
5,000 | $23.41 | $117,050 | 6,000 (Direct) |
View |
| 2021-09-16 Sale |
2021-09-20 5:00 pm |
Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks |
6,103 | $6.73 | $41,073 | 13,897 (Direct) |
View |
| 2021-02-03 Sale |
2021-02-05 6:55 pm |
Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer |
2,477 | $22.09 | $54,717 | 411,680 (Direct) |
View |
| 2020-07-01 Sale |
2020-07-02 4:13 pm |
Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer |
29,589 | $25.37 | $750,678 | 0 (Direct) |
View |
| 2020-06-10 Sale |
2020-06-12 5:50 pm |
Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer |
13,752 | $25.07 | $344,763 | 141,778 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-03-03 Option Award |
2025-03-04 9:13 pm |
N/A 2035-03-03 |
Viridian Therapeutics Inc. | VRDN | Beetham Thomas W. Chief Operating Officer |
263,450 | $0 | 263,450 (Direct) |
View |
| 2023-10-30 Option Award |
2023-11-01 4:35 pm |
N/A 2023-10-30 |
Viridian Therapeutics Inc. | VRDN | Beetham Thomas W. Chief Operating Officer |
474,400 | $0 | 474,400 (Direct) |
View |
| 2022-11-30 Option Award |
2022-12-02 4:26 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks |
3,000 | $0.94 | 19,897 (Direct) |
View |
| 2022-08-01 Option Award |
2022-08-01 9:14 pm |
N/A 2032-07-31 |
Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks |
75,000 | $0 | 75,000 (Direct) |
View |
| 2022-05-31 Option Award |
2022-06-06 4:05 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks |
3,000 | $0.99 | 16,897 (Direct) |
View |
| 2022-05-17 Option Award |
2022-05-19 4:18 pm |
N/A 2032-05-16 |
Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-02-15 Option Award |
2022-02-17 5:15 pm |
N/A 2032-02-14 |
Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks |
75,000 | $0 | 75,000 (Direct) |
View |
| 2021-09-14 Option Award |
2021-09-16 7:39 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks |
20,000 | $0 | 20,000 (Direct) |
View |
| 2021-06-14 Option Award |
2021-06-15 4:33 pm |
N/A 2031-06-13 |
Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks |
200,000 | $0 | 200,000 (Direct) |
View |
Ownership |
2021-06-15 4:29 pm |
N/A N/A |
Magenta Therapeutics Inc. | MGTA | Beetham Thomas W. See Remarks |
0 | $0 | 0 (Direct) |
View |
| 2021-03-20 Option Award |
2021-03-23 5:32 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer |
10,142 | $0 | 10,142 (Direct) |
View |
| 2021-03-16 Option Award |
2021-03-18 7:07 pm |
N/A 2031-03-15 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer |
61,380 | $0 | 61,380 (Direct) |
View |
| 2021-02-03 Conversion |
2021-02-05 6:55 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer |
300,000 | $0 | 411,680 (Direct) |
View |
| 2020-09-10 Option Award |
2020-09-14 5:14 pm |
N/A 2030-09-09 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer |
75,000 | $0 | 75,000 (Direct) |
View |
| 2020-06-10 Exercise |
2020-06-12 5:50 pm |
N/A 2025-12-15 |
Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer |
13,752 | $0 | 141,778 (Direct) |
View |
| 2020-06-10 Exercise |
2020-06-12 5:50 pm |
N/A N/A |
Kiniksa Pharmaceuticals Ltd. | KNSA | Beetham Thomas W. EVP & Chief Legal Officer |
13,752 | $1.59 | 141,778 (Direct) |
View |